Pharmaceutical Technology
July 02, 2017
41
7
A staggering percentage of people do not take their medication correctly, but pharmaceutical packaging aims to improve patient compliance using new technology to address reasons for non-adherence.
July 02, 2017
41
7
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
July 02, 2017
41
7
Oral solid-dosage and parenteral drug manufacturing equipment and systems have made great strides in safety and efficiency.
July 02, 2017
41
7
Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Patheon, shared his perspective of changes to solid-dosage pharmaceutical manufacturing.
July 02, 2017
41
7
Industry experts discuss how advances in analytical testing tools have helped address challenges in pharmaceutical analysis.
July 02, 2017
Product Spotlight
41
7
Ribbon Blenders from Ross, Charles & Son can be used to mix powders, granules, and other dry solids.
July 02, 2017
Product Spotlight
41
7
Tablet coating from DISONA can handle batch sizes up to 3 kg.
July 02, 2017
Product Spotlight
41
7
A bathless dissolution tester from Distek operates without a water bath and associated maintenance.
July 02, 2017
Product Spotlight
41
7
The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.
July 02, 2017
41
7
CDER’s Janet Woodcock endorses modern drug manufacturing to ensure access to safe and reliable medicines.
July 02, 2017
41
7
Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.
July 02, 2017
41
7
Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.
July 02, 2017
41
7
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
July 02, 2017
41
7
Real-time alternatives to dissolution testing are required for continuous manufacturing to reach mainstream use.
July 02, 2017
41
7
New ADC therapies must overcome manufacturing challenges to reach market.
July 02, 2017
41
7
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
July 02, 2017
41
7
How has the bio/pharmaceutical contract manufacturing industry evolved over the years and what does the future hold?
July 02, 2017
41
7
As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.
July 02, 2017
From the Editor and Publisher
41
7
Pharmaceutical Technology marks 40 years covering the bio/pharma industry.
July 02, 2017
Focus
41
7
The more pharma science and technology change, the more business and policy concerns stay the same.
July 02, 2017
Peer-Reviewed Research
41
7
Incorporating structural constraints into pharmacokinetic studies of iron sucrose formulations.
July 02, 2017
Features
41
7
Polymers and surfactants impact stability and long-term performance.
July 02, 2017
Ask the Expert
41
7
The opening presentation gives the company a chance to put their best foot forward, according to Siegfried Schmitt, principal at PAREXEL.
July 02, 2017
Features
41
7
FDA is working with manufacturers to encourage industry innovation.
July 02, 2017
Features
41
7
This article presents a general strategy for authorship of deviation investigations, with primary focus on regulatory inspection success.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Russell Madsen, president, The Williamsburg Group, and member of the Pharmaceutical Technology editorial advisory board, shares his thoughts on technology innovations and regulatory implications.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Biotech-based therapies and a move to single-use processes highlight recent industry changes.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Excipients play a key role in the development in emerging dosage forms but attention to quality is crucial.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
ISPE measures impact of biotechnology and globalization on personalized medicine.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Drug costs, biosimilars, and cloud-based technologies will shape the pharmaceutical industry in the years to come.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Cheaper drugs are good for consumers, but cost restrictions limit drug company incentives to modernize facilities.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Regulations and business changes have altered Big Pharma’s place in the industry.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
Advancements in cell culture and protein technology have opened the door for new therapies.
July 02, 2017
41
7
Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.
July 02, 2017
Expert Perspectives on Pharma Industry
41
7
FDA’s process validation guidance has evolved and the current lifecycle approach has profoundly influenced validation practice.
July 02, 2017
From Pharmaceutical Technology Europe
41
7
Pharmaceutical Technology marks 40 years of publishing.
July 02, 2017
From Pharmaceutical Technology Europe
41
7
Greater transparency and reliability of information are needed in the quality assessments of biosimilars.
July 02, 2017
From Pharmaceutical Technology Europe
41
7
The author reviews key technological expectations of EU GMP inspectors on the integrity of e-records.
July 02, 2017
Issue PDF
41
7
Click the title above to open the Pharmaceutical Technology July 2017 issue in an interactive PDF format.